Silo Pharma Inc (SILO) — Cash Flow Quality Index
Silo Pharma Inc (SILO) has a Cash Flow Quality Index of -1.25x as of June 2025. Operating cash flow of $-1.29 Million is below net income of $1.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Silo Pharma Inc (SILO) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Silo Pharma Inc Cash Flow Quality Index (2013–2021)
Historical Cash Flow Quality Index for Silo Pharma Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Silo Pharma Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Silo Pharma Inc (2013–2021)
Year-by-year earnings quality comparison for Silo Pharma Inc. For live market cap and the full company financial profile, see Silo Pharma Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.55x | $-2.28 Million | $4.16 Million | ▲ +31.4% |
| 2017 | -0.80x | $-284.62K | $356.54K | ▲ +85.5% |
| 2013 | -5.52x | $-181.61K | $32.91K | — |